David Rolfe - Wedgewood Partners Inc
Holding/activity history for Edwards Lifesciences Corp. (EW)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 170,969 | 2.83 | Reduce 5.48% | 0.16 | $80.08 | $13,691,198 | SEC |
| 2025 Q4 | 180,882 | 2.88 | Reduce 2.07% | 0.05 | $85.25 | $15,420,191 | SEC |
| 2025 Q3 | 184,701 | 2.62 | Add 3.74% | 0.09 | $77.77 | $14,364,197 | SEC |
| 2025 Q2 | 178,034 | 2.77 | Reduce 7.19% | 0.21 | $80.09 | $14,258,743 | SEC |
| 2025 Q1 | 191,818 | 2.97 | Reduce 43.49% | 2.15 | $76.75 | $14,722,032 | SEC |
| 2024 Q4 | 339,436 | 4.95 | Reduce 5.52% | 0.24 | $74.03 | $25,128,447 | SEC |
| 2024 Q3 | 359,257 | 4.34 | Add 1.36% | 0.06 | $66.52 | $23,897,776 | SEC |
| 2024 Q2 | 354,427 | 4.74 | Add 44.40% | 1.46 | $65.54 | $23,229,146 | SEC |
| 2024 Q1 | 245,451 | 4.43 | Reduce 2.07% | 0.09 | $90.16 | $22,129,862 | SEC |
| 2023 Q4 | 250,652 | 4.55 | Add 29.34% | 1.03 | $86.26 | $21,621,198 | SEC |
| 2023 Q3 | 193,797 | 3.21 | Reduce 38.51% | 1.84 | $69.28 | $13,426,256 | SEC |
| 2023 Q2 | 315,173 | 4.79 | Reduce 4.51% | 0.21 | $94.33 | $29,729,000 | SEC |
| 2023 Q1 | 330,070 | 4.63 | Reduce 1.11% | 0.05 | $82.73 | $27,306,000 | SEC |
| 2022 Q4 | 333,760 | 4.57 | Add 0.64% | 0.03 | $74.61 | $24,901,000 | SEC |
| 2022 Q3 | 331,627 | 5.16 | Reduce 2.66% | 0.15 | $82.63 | $27,402,000 | SEC |
| 2022 Q2 | 340,689 | 5.60 | Reduce 4.89% | 0.29 | $95.09 | $32,395,000 | SEC |
| 2022 Q1 | 358,220 | 5.95 | Add 1.44% | 0.08 | $117.72 | $42,169,000 | SEC |
| 2021 Q4 | 353,149 | 6.07 | Reduce 25.28% | 1.91 | $129.55 | $45,749,000 | SEC |
| 2021 Q3 | 472,627 | 7.55 | Reduce 2.26% | 0.16 | $113.21 | $53,506,000 | SEC |
| 2021 Q2 | 483,536 | 7.26 | Reduce 5.91% | 0.39 | $103.57 | $50,078,000 | SEC |
| 2021 Q1 | 513,888 | 6.62 | Reduce 13.63% | 1.10 | $83.64 | $42,981,000 | SEC |
| 2020 Q4 | 594,956 | 8.07 | Reduce 5.82% | 0.46 | $91.23 | $54,277,000 | SEC |
| 2020 Q3 | 631,718 | 7.97 | Reduce 5.51% | 0.43 | $79.82 | $50,423,000 | SEC |
| 2020 Q2 | 668,542 | 7.83 | Add 181.85% | 5.05 | $69.11 | $46,202,000 | SEC |
| 2020 Q1 | 237,200 | 8.48 | Reduce 36.59% | 3.24 | $188.62 | $44,740,000 | SEC |
| 2019 Q4 | 374,062 | 8.85 | Reduce 21.87% | 2.04 | $233.29 | $87,264,000 | SEC |
| 2019 Q3 | 478,789 | 9.33 | Reduce 7.98% | 0.65 | $219.91 | $105,289,000 | SEC |
| 2019 Q2 | 520,293 | 8.14 | Reduce 21.27% | 1.96 | $184.74 | $96,117,000 | SEC |
| 2019 Q1 | 660,819 | 9.23 | Reduce 19.52% | 1.63 | $191.33 | $126,434,000 | SEC |
| 2018 Q4 | 821,132 | 8.35 | Add 0.27% | 0.02 | $153.17 | $125,772,000 | SEC |
| 2018 Q3 | 818,960 | 7.15 | Reduce 8.13% | 0.53 | $174.10 | $142,580,000 | SEC |
| 2018 Q2 | 891,410 | 6.55 | Reduce 21.28% | 1.55 | $145.57 | $129,762,000 | SEC |
| 2018 Q1 | 1,132,341 | 7.27 | Reduce 15.48% | 0.95 | $139.52 | $157,983,000 | SEC |
| 2017 Q4 | 1,339,762 | 6.11 | Reduce 0.24% | 0.01 | $112.71 | $151,004,000 | SEC |
| 2017 Q3 | 1,343,047 | 5.01 | Add 55.92% | 1.80 | $109.31 | $146,807,000 | SEC |
| 2017 Q2 | 861,348 | 3.12 | Reduce 24.25% | 0.67 | $118.24 | $101,844,000 | SEC |
| 2017 Q1 | 1,137,072 | 2.76 | Buy | 2.76 | $94.07 | $106,963,000 | SEC |